Eosinophilic dysplasia of the cervix: A newly recognized variant of cervical squamous intraepithelial neoplasia

American Journal of Surgical Pathology

Volumn 28, Issue 11, 2004, Pages 1474-1484

  Ma, Linglei ^a   Fisk, John M ^a   Zhang, Roy R ^a   Ulukus, E Cagnur ^a   Crum, Christopher P ^b   Zheng, Wenxin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Cervical carcinoma; Cervical dysplasia; CIN

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL MATURATION; CLINICAL ARTICLE; CONDYLOMA; CONTROLLED STUDY; EOSINOPHILIC DYSPLASIA; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NUCLEOLUS; PAPANICOLAOU TEST; PROTEIN EXPRESSION; SQUAMOUS CELL METAPLASIA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA; WART VIRUS;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA PROBES, HPV; EOSINOPHILIA; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 7044224927     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000141407.10204.c5     Document Type: Article

References (36)

1. Aagaard L, Lukas J, Bartkova J, et al. Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines. Int J Cancer. 1995;61:115-120.
2. al-Saleh W, Delvenne P, Greimers R, et al. Assessment of Ki-67 antigen immunostaining in squamous intraepithelial lesions of the uterine cervix: correlation with the histologic grade and human papillomavirus type. Am J Clin Pathol. 1995;104:154-160.
3. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357-363.
4. Dunton CJ, van Hoeven KH, Kovatich AJ, et al. Ki-67 antigen staining as an adjunct to identifying cervical intraepithelial neoplasia. Gynecol Oncol. 1997;64:451-455.
5. Dyson N, Howley PM, Munger K, et al. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934-937.
6. Genest DR, Stein L, Cibas E, et al. A binary (Bethesda) system for classifying cervical cancer precursors: criteria, reproducibility, and viral correlates. Hum Pathol. 1993;24:730-736.
7. Geng L, Connolly DC, Isacson C, et al. Atypical immature metaplasia (AIM) of the cervix: is it related to high-grade squamous intraepithelial lesion (HSIL)? Hum Pathol. 1999;30:345-351.
8. Isacson C, Kessis TD, Hedrick L, et al. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res. 1996;56:669-674.
9. Kalantari M, Karlsen F, Johansson B, et al. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol. 1997;28:899-904.
10. Karlsen F, Kalantari M, Jenkins A, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 1996; 34:2095-2100.
11. Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001;25:884-891.
12. Kessis TD, Silberman MA, Sherman M, et al. Rapid identification of patient specimens with microsatellite DNA markers. Mod Pathol. 1996;9: 183-188.
13. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284.
14. Lorincz AT, Reid R, Jenson AB, et al. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992;79:328-337.
15. Lungu O, Wright TCJ, Silverstein S. Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis. Mol Cell Probes. 1992;6:145-152.
16. Manos MM. HPV testing for clarifying borderline cervical smear results. Br Med J. 2001;322:878-879.
17. Manos MM, Ting Y, Wright DK, et al. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells. 1989;7:209-214.
18. Nakao Y, Yang X, Yokoyama M, et al. Induction of p16 during immortalization by HPV 16 and 18 and not during malignant transformation. Br J Cancer. 1997;75:1410-1416.
19. Park JJ, Genest DR, Sun D, et al. Atypical immature metaplastic-like proliferations of the cervix: diagnostic reproducibility and viral (HPV) correlates. Hum Pathol. 1999;30:1161-1165.
20. Park JS, Dong SM, Kim HS, et al. Detection of p16 gene alteration in cervical cancer using tissue microdissection and LOH study. Cancer Lett. 1999;136:101-108.
21. Pirog EC, Isacson C, Szabolcs MJ, et al. Proliferative activity of benign and neoplastic endocervical epithelium and correlation with HPV DNA detection. Int J Gynecol Pathol. 2002;21:22-26.
22. Quade BJ, Yang A, Wang Y, et al. Expression of the p53 homologue p63 in early cervical neoplasia. Gynecol Oncol. 2001;80:24-29.
23. Sano T, Oyama T, Kashiwabara K, et al. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998;153:1741-1748.
24. Scholz RB, Milde-Langosch K, Jung R, et al. Rapid screening for Tp53 mutations by temperature gradient gel electrophoresis: a comparison with SSCP analysis. Hum Mol Genet. 1993;2:2155-2158.
25. Sherman ME, Schiffman M, Cox JT. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2002;94:102-107.
26. Solomon D, Schiffman M, Tarone R. ALTS Study group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001;93:293-299.
27. Stanley MA. Prognostic factors and new therapeutic approaches to cervical cancer. Virus Res. 2002;89:241-248.
28. Tate JE, Resnick M, Sheets EE, et al. Absence of papillomavirus DNA in normal tissue adjacent to most cervical intraepithelial neoplasms. Obstet Gynecol. 1996;88:257-260.
29. van Hoeven KH, Ramondetta L, Kovatich AJ, et al. Quantitative image analysis of MIB-1 reactivity in inflammatory, hyperplastic, and neoplastic endocervical lesions. Int J Gynecol Pathol. 1997;16:15-21.
30. Vizcaino AP, Moreno V, Bosch FX, et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer. 2000;86: 429-435.
31. Ward BE, Saleh AM, Williams JV, et al. Papillary immature metaplasia of the cervix: a distinct subset of exophytic cervical condyloma associated with HPV-6/11 nucleic acids. Mod Pathol. 1992;5:391-395.
32. Xiong Y, Kuppuswamy D, Li Y, et al. Alteration of cell cycle kinase complexes in human papillomavirus E6- and E7-expressing fibroblasts precedes neoplastic transformation. J Virol. 1996;70:999-1008.
33. Zheng W, Khurana R, Farahmand S, et al. p53 immunostaining as an significant diagnostic marker for uterine surface carcinoma: precursor lesion of uterine papillary serous carcinoma. Am J Surg Pathol. 1998;22: 1463-1473.
34. Zheng W, Luo F, Lu J, et al. Reduction of BRCA1 expression in sporadic ovarian cancer [see comment]. Gynecol Oncol. 2000;76:294-300.
35. zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta. 1996;1288:F55-F78.
36. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92: 690-698.